Country: Germany Exchange: Frankfurt Sector: Healthcare Industry: Biotechnology Stock Market - Quotes & Prices
List of all Stocks and Equities with Prices, Market Capitalizations, PE and EPS
Germany (648)
- {{country.name}}
- All countries
- Germany (648)
Frankfurt (648)
Healthcare (648)
- {{item.name}}
- All sectors
- Healthcare (648)
Biotechnology (648)
- {{item.name}}
- All Industries
- Biotechnology (648)
- Drug Manufacturers-General (45)
- Drug Manufacturers-Specialty & Generic (276)
- Healthcare Plans (9)
- Medical Care Facilities (93)
- Pharmaceutical Retailers (21)
- Health Information Services (81)
- Medical Devices (201)
- Medical Instruments & Supplies (106)
- Diagnostics & Research (101)
- Medical Distribution (22)
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
M.Cap Market Cap | VOL Volume | 24h low | 24h high | Market Cap | P/E Ratio | EPS |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
M.Cap Market Cap | VOL Volume | 24h low | 24h high | Market Cap | P/E Ratio | EPS | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Novavax, Inc. NVV1.F | $13.37 14.61 USD |
+13.27
|
$1.99B 2.18B USD | $29.5K 32.25K USD | $11.24 12.29 USD | $13.37 14.61 USD | $1.99B 2.18B USD | 0 | -$2.82 -3.08 USD | |
| CureVac N.V. 5CV.F | $3.15 3.44 USD |
+5.42
|
$706.56M 772.37M USD | $37.39K 40.87K USD | $2.9 3.17 USD | $3.3 3.61 USD | $706.56M 772.37M USD | 0 | -$1.18 -1.2 USD | |
| Valneva SE AYJ.F | $4.07 4.45 USD |
+0.49
|
$567.19M 620.01M USD | $13.11K 14.33K USD | $4.01 4.38 USD | $4.25 4.65 USD | $567.19M 620.01M USD | 0 | -$0.19 -0.2 USD | |
| Ocugen, Inc. 2H51.F | $1.8 1.97 USD |
-1.37
|
$464.22M 507.45M USD | $18.32K 20.02K USD | $1.71 1.87 USD | $1.89 2.07 USD | $464.22M 507.45M USD | 0 | -$0.24 -0.2 USD | |
| Atai Life Sciences N.V. 9VC.F | $1.88 2.06 USD |
+3.8
|
$329.43M 360.11M USD | $1.23K 1.34K USD | $1.88 2.06 USD | $1.88 2.06 USD | $329.43M 360.11M USD | 0 | -$0.23 -0.2 USD | |
| Sernova Corp. PSH.F | $0.25 0.27 USD |
+8.64
|
$78.13M 85.41M USD | $1K 1.09K USD | $0.23 0.25 USD | $0.25 0.27 USD | $78.13M 85.41M USD | 0 | -$0.09 -0.09 USD | |
| Defence Therapeutics Inc. DTC.F | $0.9 0.98 USD |
-0.44
|
$40.71M 44.5M USD | $5.8K 6.34K USD | $0.8499 0.93 USD | $0.9 0.98 USD | $40.71M 44.5M USD | 0 | -$0.13 -0.1 USD | |
| IntelGenx Technologies Corp. 0IL.F | $0.1199 0.13 USD |
-8.46
|
$25.65M 28.04M USD | $140K 153.04K USD | $0.1199 0.13 USD | $0.1199 0.13 USD | $25.65M 28.04M USD | 0 | -$0.06 -0.06 USD | |
| Vivoryon Therapeutics N.V. 05Y.F | $0.7399 0.81 USD |
-3.51
|
$19.37M 21.17M USD | $8.5K 9.29K USD | $0.7399 0.81 USD | $0.7399 0.81 USD | $19.37M 21.17M USD | 0 | -$1.12 -1.2 USD | |
| Alterity Therapeutics Limited PBN.F | $0.0015 0.0016 USD |
0
|
$16.04M 17.54M USD | $300 327.94 USD | $0.0015 0.0016 USD | $0.0015 0.0016 USD | $16.04M 17.54M USD | 0 | $0 0 USD | |
| Sirona Biochem Corp. ZSB.F | $0.04 0.04 USD |
0
|
$10.37M 11.33M USD | $200 218.63 USD | $0.04 0.04 USD | $0.04 0.04 USD | $10.37M 11.33M USD | 0 | $0 0 USD | |
| Core One Labs Inc. LD6.F | $0.13 0.14 USD |
-12.11
|
$5.98M 6.54M USD | $24.21K 26.47K USD | $0.13 0.14 USD | $0.14 0.16 USD | $5.98M 6.54M USD | 0 | -$0.07 -0.07 USD | |
| BioVaxys Technology Corp. 5LB.F | $0.04 0.04 USD |
-17.98
|
$5.84M 6.39M USD | $20K 21.86K USD | $0.04 0.04 USD | $0.04 0.04 USD | $5.84M 6.39M USD | 0 | -$0.08 -0.08 USD | |
| Cyxone AB (publ) 4CX.F | $0.004799 0.0052 USD |
+140
|
$5.29M 5.79M USD | $10K 10.93K USD | $0.004799 0.0052 USD | $0.004799 0.0052 USD | $5.29M 5.79M USD | 0 | -$0.02 -0.02 USD | |
| RVL Pharmaceuticals plc O1P.F | $0.003 0.0032 USD |
0
|
$1.9M 2.07M USD | $1 1.09 USD | $0.003 0.0032 USD | $0.003 0.0032 USD | $1.9M 2.07M USD | 0 | -$0.67 -0.7 USD | |
| Braxia Scientific Corp. 4960.F | $0.005 0.0054 USD |
+66.67
|
$1.6M 1.75M USD | $43.47K 47.51K USD | $0.0015 0.0016 USD | $0.005 0.0054 USD | $1.6M 1.75M USD | 0 | -$0.03 -0.03 USD | |
| Oxurion NV TG4.F | $0.0001 0.00010 USD |
0
|
$1.01M 1.1M USD | $2.5K 2.73K USD | $0.0001 0.00010 USD | $0.0001 0.00010 USD | $1.01M 1.1M USD | 0 | -$0.01 -0.01 USD | |
| Amniotics AB (publ) 66J.F | $0.0002 0.00021 USD |
0
|
$887.98K 970.68K USD | $100K 109.31K USD | $0.0002 0.00021 USD | $0.0002 0.00021 USD | $887.98K 970.68K USD | 0 | -$0.01 -0.01 USD | |
| Bioasis Technologies Inc. 107.F | $0.008 0.0087 USD |
0
|
$635.31K 694.48K USD | $180K 196.76K USD | $0.005 0.0054 USD | $0.008 0.0087 USD | $635.31K 694.48K USD | 0 | -$0.03 -0.03 USD | |
| Novo Nordisk A/S NOVA.F | $122.5 133.91 USD |
-0.81
|
$545.72B 596.54B USD | $2.02K 2.2K USD | $120 131.18 USD | $123.5 135 USD | $545.72B 596.54B USD | 45.88 | $2.67 2.92 USD | |
| Vertex Pharmaceuticals Incorporated VX1.F | $403.05 440.59 USD |
+0.04
|
$104.44B 114.16B USD | $11 12.02 USD | $400.05 437.31 USD | $403.05 440.59 USD | $104.44B 114.16B USD | 28.26 | $14.26 15.59 USD | |
| CSL Limited CSJA.F | $87 95.1 USD |
+1.16
|
$84.76B 92.65B USD | $10 10.93 USD | $87 95.1 USD | $87 95.1 USD | $84.76B 92.65B USD | 36.86 | $2.36 2.58 USD | |
| CSL Limited CSJ.F | $174.62 190.88 USD |
+1.09
|
$84.69B 92.58B USD | $10 10.93 USD | $174.62 190.88 USD | $174.62 190.88 USD | $84.69B 92.58B USD | 37.15 | $4.7 5.14 USD | |
| Moderna, Inc. 0QF.F | $122 133.36 USD |
+4.11
|
$47.62B 52.05B USD | $185 202.23 USD | $118.22 129.23 USD | $122 133.36 USD | $47.62B 52.05B USD | 0 | -$14.41 -15.7 USD | |
| Seagen Inc. SGT.F | $208.6 228.03 USD |
0
|
$39.36B 43.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $39.36B 43.02B USD | 0 | $0 0 USD | |
| UCB SA UNC0.F | $60.5 66.13 USD |
+2.54
|
$23.85B 26.07B USD | $4 4.37 USD | $60.5 66.13 USD | $60.5 66.13 USD | $23.85B 26.07B USD | 68.75 | $0.88 0.96 USD | |
| UCB SA UNC.F | $122.65 134.07 USD |
+1.83
|
$23.68B 25.89B USD | $40 43.73 USD | $122.65 134.07 USD | $122.65 134.07 USD | $23.68B 25.89B USD | 69.68 | $1.76 1.92 USD | |
| argenx SE 1AEA.F | $342 373.85 USD |
+5.56
|
$21.64B 23.66B USD | $10 10.93 USD | $342 373.85 USD | $342 373.85 USD | $21.64B 23.66B USD | 0 | -$5.25 -5.7 USD | |
| argenx SE 1AE.F | $342.8 374.73 USD |
+4.29
|
$21.38B 23.37B USD | $2 2.19 USD | $342.8 374.73 USD | $342.8 374.73 USD | $21.38B 23.37B USD | 0 | -$5.26 -5.7 USD | |
| BioNTech SE 22UA.F | $84.65 92.53 USD |
+0.53
|
$20.66B 22.58B USD | $741 810.01 USD | $84.1 91.93 USD | $85.95 93.95 USD | $20.66B 22.58B USD | 180.10 | $0.47 0.51 USD | |
| BeiGene, Ltd. 49BA.F | $155 169.44 USD |
+4.73
|
$17.58B 19.22B USD | $20 21.86 USD | $153 167.25 USD | $155 169.44 USD | $17.58B 19.22B USD | 0 | -$6.97 -7.6 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.F | $134.5 147.03 USD |
-0.88
|
$17.09B 18.68B USD | $7 7.65 USD | $134.5 147.03 USD | $134.5 147.03 USD | $17.09B 18.68B USD | 0 | -$2.44 -2.6 USD | |
| BeiGene, Ltd. 49B.F | $11.8 12.9 USD |
+2.61
|
$16.93B 18.5B USD | $340 371.67 USD | $11.8 12.9 USD | $11.8 12.9 USD | $16.93B 18.5B USD | 0 | -$0.54 -0.5 USD | |
| Royalty Pharma plc RPD.F | $25.45 27.82 USD |
-1.09
|
$15.42B 16.85B USD | $50 54.66 USD | $25.45 27.82 USD | $25.51 27.89 USD | $15.42B 16.85B USD | 15.42 | $1.65 1.8 USD | |
| BioMarin Pharmaceutical Inc. BM8.F | $74.12 81.02 USD |
+1.06
|
$14.27B 15.6B USD | $200 218.63 USD | $73.64 80.5 USD | $74.12 81.02 USD | $14.27B 15.6B USD | 75.63 | $0.98 1.07 USD | |
| Bio-Techne Corporation TE1.F | $76 83.08 USD |
-3.18
|
$11.98B 13.09B USD | $2 2.19 USD | $76 83.08 USD | $76 83.08 USD | $11.98B 13.09B USD | 66.08 | $1.15 1.26 USD | |
| Incyte Corporation ICY.F | $52 56.84 USD |
-1.14
|
$11.73B 12.82B USD | $140 153.04 USD | $52 56.84 USD | $52.42 57.3 USD | $11.73B 12.82B USD | 17.04 | $3.05 3.33 USD | |
| Sarepta Therapeutics, Inc. AB3A.F | $121.2 132.49 USD |
-0.7
|
$11.5B 12.57B USD | $38 41.54 USD | $121.2 132.49 USD | $121.2 132.49 USD | $11.5B 12.57B USD | 303.00 | $0.4 0.44 USD | |
| United Therapeutics Corporation UTH.F | $249 272.19 USD |
+0.65
|
$11.26B 12.31B USD | $15 16.4 USD | $249 272.19 USD | $249 272.19 USD | $11.26B 12.31B USD | 12.75 | $19.52 21.34 USD | |
| Roivant Sciences Ltd. 87S.F | $10.15 11.09 USD |
+0.9
|
$8.65B 9.45B USD | $1K 1.09K USD | $10.1 11.04 USD | $10.15 11.09 USD | $8.65B 9.45B USD | 2.08 | $4.87 5.32 USD | |
| ImmunoGen, Inc. IMU.F | $28.74 31.42 USD |
0
|
$8.08B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.08B 8.83B USD | 0 | $0 0 USD | |
| Legend Biotech Corporation 9LB.F | $42.2 46.13 USD |
+0.96
|
$7.79B 8.51B USD | $20 21.86 USD | $41.6 45.47 USD | $42.2 46.13 USD | $7.79B 8.51B USD | 0 | -$2.39 -2.6 USD | |
| Vaxcyte, Inc. 5VA.F | $65.5 71.6 USD |
+5.65
|
$7.61B 8.32B USD | $4 4.37 USD | $65.5 71.6 USD | $65.5 71.6 USD | $7.61B 8.32B USD | 0 | -$3.97 -4.3 USD | |
| Innovent Biologics, Inc. 6IB.F | $4.64 5.07 USD |
0
|
$7.57B 8.28B USD | $520 568.43 USD | $4.62 5.05 USD | $4.64 5.07 USD | $7.57B 8.28B USD | 0 | -$0.08 -0.08 USD | |
| WuXi Biologics (Cayman) Inc. 1FW2.F | $1.73 1.89 USD |
+2.38
|
$7.31B 7.99B USD | $800 874.51 USD | $1.71 1.87 USD | $1.76 1.93 USD | $7.31B 7.99B USD | 17.29 | $0.1 0.11 USD | |
| WuXi Biologics (Cayman) Inc. 1FW1.F | $3.3 3.61 USD |
+1.23
|
$7.22B 7.9B USD | $1.05K 1.14K USD | $3.3 3.61 USD | $3.3 3.61 USD | $7.22B 7.9B USD | 16.50 | $0.2 0.22 USD | |
| Viking Therapeutics, Inc. 1VT.F | $63.14 69.02 USD |
-11.37
|
$7.05B 7.7B USD | $2.19K 2.4K USD | $63.14 69.02 USD | $72.02 78.73 USD | $7.05B 7.7B USD | 0 | -$0.85 -0.9 USD | |
| Sino Biopharmaceutical Limited SMZ1.F | $0.3599 0.39 USD |
+1.58
|
$6.91B 7.56B USD | $1.4K 1.53K USD | $0.3599 0.39 USD | $0.3599 0.39 USD | $6.91B 7.56B USD | 35.99 | $0.01 0.01 USD | |
| Ascendis Pharma A/S A71.F | $114 124.62 USD |
-0.87
|
$6.45B 7.06B USD | $1K 1.09K USD | $114 124.62 USD | $114 124.62 USD | $6.45B 7.06B USD | 0 | -$8.87 -9.6 USD | |
| Jazz Pharmaceuticals plc J7Z.F | $101.05 110.46 USD |
+0.1
|
$6.4B 7B USD | $888 970.7 USD | $100.15 109.48 USD | $101.05 110.46 USD | $6.4B 7B USD | 22.65 | $4.46 4.88 USD | |
| Revolution Medicines, Inc. 42Z.F | $36 39.35 USD |
+4.65
|
$6.29B 6.87B USD | $30 32.79 USD | $36 39.35 USD | $36 39.35 USD | $6.29B 6.87B USD | 0 | -$3.55 -3.8 USD | |
| Blueprint Medicines Corporation 2L9.F | $97.7 106.8 USD |
-0.55
|
$6.15B 6.72B USD | $137 149.76 USD | $96.78 105.79 USD | $101.1 110.52 USD | $6.15B 6.72B USD | 0 | -$4.46 -4.8 USD | |
| Cytokinetics, Incorporated KK3A.F | $55 60.12 USD |
+2.8
|
$6.03B 6.59B USD | $200 218.63 USD | $55 60.12 USD | $55 60.12 USD | $6.03B 6.59B USD | 0 | -$4.99 -5.4 USD | |
| Exelixis, Inc. EX9.F | $19.23 21.02 USD |
+0.16
|
$5.7B 6.23B USD | $47 51.38 USD | $19.23 21.02 USD | $19.23 21.02 USD | $5.7B 6.23B USD | 32.04 | $0.6 0.66 USD | |
| Halozyme Therapeutics, Inc. RV7.F | $41.96 45.87 USD |
+4.09
|
$5.61B 6.14B USD | $5 5.47 USD | $41.96 45.87 USD | $41.96 45.87 USD | $5.61B 6.14B USD | 18.81 | $2.23 2.44 USD | |
| Akeso, Inc. 4RY.F | $5.8 6.34 USD |
+4.5
|
$5.27B 5.76B USD | $351 383.69 USD | $5.8 6.34 USD | $5.8 6.34 USD | $5.27B 5.76B USD | 18.70 | $0.31 0.34 USD | |
| Ionis Pharmaceuticals, Inc. ISI.F | $34.99 38.25 USD |
-0.54
|
$5.26B 5.75B USD | $1.2K 1.31K USD | $34.99 38.25 USD | $36.22 39.59 USD | $5.26B 5.75B USD | 0 | -$2.47 -2.7 USD | |
| BridgeBio Pharma, Inc. 2CL.F | $27.49 30.05 USD |
+0.62
|
$5.22B 5.7B USD | $300 327.94 USD | $27.31 29.85 USD | $27.49 30.05 USD | $5.22B 5.7B USD | 0 | -$2.99 -3.2 USD | |
| ImmunityBio, Inc. 26CA.F | $7.1 7.76 USD |
-3.77
|
$4.98B 5.45B USD | $1.32K 1.44K USD | $7.05 7.71 USD | $7.26 7.94 USD | $4.98B 5.45B USD | 0 | -$1 -1.09 USD | |
| Abcam plc A8C3.F | $11.7 12.79 USD |
0
|
$4.82B 5.27B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.82B 5.27B USD | 0 | $0 0 USD | |
| Apellis Pharmaceuticals, Inc. 1JK.F | $38.44 42.01 USD |
-1.68
|
$4.66B 5.1B USD | $20 21.86 USD | $37.83 41.35 USD | $38.44 42.01 USD | $4.66B 5.1B USD | 0 | -$3.17 -3.4 USD | |
| ALK-Abelló A/S 4AJ0.F | $20.5 22.41 USD |
+0.79
|
$4.64B 5.07B USD | $2.16K 2.36K USD | $20.5 22.41 USD | $20.5 22.41 USD | $4.64B 5.07B USD | 58.57 | $0.35 0.38 USD | |
| Krystal Biotech, Inc. 4KB.F | $149.05 162.93 USD |
+1.78
|
$4.39B 4.79B USD | $7 7.65 USD | $149.05 162.93 USD | $149.05 162.93 USD | $4.39B 4.79B USD | 73.78 | $2.02 2.21 USD | |
| Laboratorios Farmaceuticos Rovi, S.A. 41L.F | $85.7 93.68 USD |
-0.46
|
$4.39B 4.79B USD | $400 437.25 USD | $85.7 93.68 USD | $85.7 93.68 USD | $4.39B 4.79B USD | 33.21 | $2.58 2.82 USD | |
| Financière de Tubize SA FTD.F | $95.1 103.96 USD |
+1.39
|
$4.33B 4.74B USD | $4 4.37 USD | $95.1 103.96 USD | $95.1 103.96 USD | $4.33B 4.74B USD | 48.03 | $1.98 2.16 USD | |
| Madrigal Pharmaceuticals, Inc. YDO1.F | $197.35 215.73 USD |
+2.1
|
$4.26B 4.66B USD | $10 10.93 USD | $192.3 210.21 USD | $197.35 215.73 USD | $4.26B 4.66B USD | 0 | -$21.39 -23.3 USD | |
| Alpine Immune Sciences, Inc. 34LA.F | $59 64.49 USD |
0
|
$4.12B 4.51B USD | $20 21.86 USD | $58.5 63.95 USD | $59 64.49 USD | $4.12B 4.51B USD | 0 | -$0.59 -0.6 USD | |
| Mirati Therapeutics, Inc. 26M.F | $53.3 58.26 USD |
0
|
$3.79B 4.14B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.79B 4.14B USD | 0 | $0 0 USD | |
| Asymchem Laboratories (Tianjin) Co., Ltd. 7K90.F | $7.3 7.98 USD |
+0.69
|
$3.76B 4.11B USD | $56 61.22 USD | $7.3 7.98 USD | $7.3 7.98 USD | $3.76B 4.11B USD | 10.73 | $0.68 0.74 USD | |
| Crinetics Pharmaceuticals, Inc. 6Z4.F | $46.2 50.5 USD |
+1.76
|
$3.75B 4.1B USD | $40 43.73 USD | $46.2 50.5 USD | $46.2 50.5 USD | $3.75B 4.1B USD | 0 | -$3.49 -3.8 USD | |
| CymaBay Therapeutics, Inc. C0I.F | $29.8 32.58 USD |
0
|
$3.43B 3.75B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.43B 3.75B USD | 0 | $0 0 USD | |
| Insmed Incorporated IM8N.F | $23 25.14 USD |
-1.71
|
$3.42B 3.74B USD | $25 27.33 USD | $23 25.14 USD | $23 25.14 USD | $3.42B 3.74B USD | 0 | -$4.84 -5.2 USD | |
| Axsome Therapeutics, Inc. 19X.F | $68.94 75.36 USD |
-2.43
|
$3.27B 3.58B USD | $200 218.63 USD | $68.94 75.36 USD | $68.94 75.36 USD | $3.27B 3.58B USD | 0 | -$5.96 -6.5 USD | |
| Genscript Biotech Corporation G51.F | $1.46 1.6 USD |
+1.39
|
$3.17B 3.46B USD | $900 983.82 USD | $1.46 1.6 USD | $1.46 1.6 USD | $3.17B 3.46B USD | 0 | -$0.04 -0.04 USD | |
| Ultragenyx Pharmaceutical Inc. UP0.F | $37.8 41.32 USD |
0
|
$3.16B 3.46B USD | $100 109.31 USD | $37.8 41.32 USD | $37.8 41.32 USD | $3.16B 3.46B USD | 0 | -$7.35 -8.03 USD | |
| Arrowhead Pharmaceuticals, Inc. HDP1.F | $22.85 24.98 USD |
+8.71
|
$3.13B 3.42B USD | $20 21.86 USD | $22.85 24.98 USD | $22.85 24.98 USD | $3.13B 3.42B USD | 0 | -$3.91 -4.2 USD | |
| IDEAYA Biosciences, Inc. 30J.F | $38.4 41.98 USD |
+1.05
|
$3B 3.28B USD | $420 459.12 USD | $38.4 41.98 USD | $38.4 41.98 USD | $3B 3.28B USD | 0 | -$1.85 -2.02 USD | |
| Denali Therapeutics Inc. 4DN.F | $18.96 20.73 USD |
+4.55
|
$2.88B 3.14B USD | $100 109.31 USD | $18.96 20.73 USD | $19.07 20.84 USD | $2.88B 3.14B USD | 0 | -$0.87 -0.9 USD | |
| Camurus AB (publ) 7CA.F | $48.62 53.15 USD |
+1.76
|
$2.84B 3.11B USD | $40 43.73 USD | $48.62 53.15 USD | $48.62 53.15 USD | $2.84B 3.11B USD | 75.96 | $0.64 0.7 USD | |
| Xenon Pharmaceuticals Inc. XP0.F | $37 40.45 USD |
-1.07
|
$2.79B 3.05B USD | $20 21.86 USD | $37 40.45 USD | $37 40.45 USD | $2.79B 3.05B USD | 0 | -$2.52 -2.7 USD | |
| Iovance Biotherapeutics, Inc. 2LB.F | $9.81 10.73 USD |
-0.69
|
$2.75B 3B USD | $501 547.66 USD | $9.81 10.73 USD | $9.81 10.73 USD | $2.75B 3B USD | 0 | -$1.67 -1.8 USD | |
| Amicus Therapeutics, Inc. AM6.F | $8.85 9.67 USD |
+3.51
|
$2.74B 2.99B USD | $850 929.16 USD | $8.85 9.67 USD | $8.85 9.67 USD | $2.74B 2.99B USD | 0 | -$0.45 -0.4 USD | |
| Corcept Therapeutics Incorporated HTD.F | $25.26 27.61 USD |
+0.04
|
$2.68B 2.93B USD | $50 54.66 USD | $25.26 27.61 USD | $25.31 27.67 USD | $2.68B 2.93B USD | 26.04 | $0.97 1.06 USD | |
| MorphoSys AG MOR2.F | $17 18.58 USD |
+3.03
|
$2.64B 2.89B USD | $100 109.31 USD | $16.5 18.04 USD | $17 18.58 USD | $2.64B 2.89B USD | 0 | -$1.38 -1.5 USD | |
| Maravai LifeSciences Holdings, Inc. MAR.F | $10.2 11.15 USD |
+0.99
|
$2.63B 2.88B USD | $25 27.33 USD | $10.2 11.15 USD | $10.4 11.37 USD | $2.63B 2.88B USD | 0 | -$0.92 -1.005 USD | |
| MorphoSys AG MOR.F | $69.8 76.3 USD |
+2.8
|
$2.63B 2.88B USD | $3.38K 3.7K USD | $67.6 73.9 USD | $70.15 76.68 USD | $2.63B 2.88B USD | 0 | -$5.53 -6.04 USD | |
| TG Therapeutics, Inc. NKB2.F | $16.15 17.65 USD |
-1.94
|
$2.5B 2.73B USD | $215 235.02 USD | $16.15 17.65 USD | $16.15 17.65 USD | $2.5B 2.73B USD | 57.66 | $0.28 0.31 USD | |
| Celldex Therapeutics, Inc. TCE2.F | $36.4 39.79 USD |
+1.11
|
$2.48B 2.71B USD | $85 92.92 USD | $36.4 39.79 USD | $36.4 39.79 USD | $2.48B 2.71B USD | 0 | -$2.65 -2.8 USD | |
| Immunocore Holdings plc 6YG.F | $49.8 54.44 USD |
-2.35
|
$2.47B 2.7B USD | $100 109.31 USD | $49.8 54.44 USD | $50.5 55.2 USD | $2.47B 2.7B USD | 0 | -$1.32 -1.4 USD | |
| Merus N.V. 2GH.F | $41 44.82 USD |
+0.49
|
$2.47B 2.7B USD | $105 114.78 USD | $41 44.82 USD | $41 44.82 USD | $2.47B 2.7B USD | 0 | -$2.53 -2.7 USD | |
| BB Biotech AG Ord BBZA.F | $42.95 46.95 USD |
+0.94
|
$2.39B 2.61B USD | $2.69K 2.94K USD | $42.3 46.24 USD | $42.95 46.95 USD | $2.39B 2.61B USD | 0 | -$3.85 -4.2 USD | |
| ACADIA Pharmaceuticals Inc. DR6.F | $13.82 15.1 USD |
+0.99
|
$2.33B 2.55B USD | $260 284.22 USD | $13.82 15.1 USD | $13.82 15.1 USD | $2.33B 2.55B USD | 0 | $0 0 USD | |
| Intellia Therapeutics, Inc. 38I.F | $23.71 25.92 USD |
-2.27
|
$2.29B 2.5B USD | $240 262.35 USD | $23.71 25.92 USD | $23.71 25.92 USD | $2.29B 2.5B USD | 0 | -$4.97 -5.4 USD | |
| Vericel Corporation ATQP.F | $45 49.19 USD |
+1.35
|
$2.25B 2.46B USD | $10 10.93 USD | $45 49.19 USD | $45 49.19 USD | $2.25B 2.46B USD | 4500.00 | $0.01 0.01 USD | |
| Rhythm Pharmaceuticals, Inc. 1RV.F | $36 39.35 USD |
-5.26
|
$2.2B 2.4B USD | $50 54.66 USD | $36 39.35 USD | $36 39.35 USD | $2.2B 2.4B USD | 0 | -$4.28 -4.6 USD | |
| Geron Corporation GON.F | $3.54 3.87 USD |
+2.25
|
$2.19B 2.39B USD | $400 437.25 USD | $3.54 3.87 USD | $3.54 3.87 USD | $2.19B 2.39B USD | 0 | -$0.32 -0.3 USD | |
| BioArctic AB (publ) B9A.F | $20.08 21.95 USD |
+12.62
|
$2.03B 2.22B USD | $450 491.91 USD | $20.08 21.95 USD | $20.44 22.34 USD | $2.03B 2.22B USD | 91.27 | $0.22 0.24 USD | |
| Rocket Pharmaceuticals, Inc. 9IP1.F | $21.61 23.62 USD |
+0.7
|
$2B 2.19B USD | $120 131.18 USD | $21.61 23.62 USD | $21.61 23.62 USD | $2B 2.19B USD | 0 | -$2.64 -2.8 USD | |
| Agios Pharmaceuticals, Inc. 8AP.F | $32.2 35.2 USD |
+2.55
|
$1.89B 2.07B USD | $100 109.31 USD | $32.2 35.2 USD | $32.2 35.2 USD | $1.89B 2.07B USD | 0 | -$5.83 -6.3 USD | |
| Catalyst Pharmaceuticals, Inc. CN2.F | $15.1 16.5 USD |
+1.04
|
$1.84B 2.01B USD | $2K 2.19K USD | $15.1 16.5 USD | $15.1 16.5 USD | $1.84B 2.01B USD | 29.02 | $0.52 0.57 USD | |
|
No favorite stocks
You do not have a favorite stocks yet, please add it to favorites to see it here |
||||||||||